entity

sess_SDA-2026-04-10-gba-pd

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about sess_SDA-2026-04-10-gba-pd: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
2Analyses
1Outgoing
0Incoming
0Experiments
2Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
processedcausal_extractedsentinel0.00

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Does TFEB activation directly restore mutant GBA enzyme activity or only enhance

molecular biology | 2026-04-11 | 0 hypotheses

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.380

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

The debate identified this as a critical mechanistic gap - TFEB may increase lys

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease?

closed · Rounds: 4 · Score: 0.89 · 2026-04-10

Related Research

Hypotheses and analyses mentioning sess_SDA-2026-04-10-gba-pd in their description or question text

No additional research found